Skip to content
Menu

Medline Inc. MDLN

Full chart Compare
Set alert

Price alert · MDLN

All alert types
37.04 USD -0.80 (-2.11%)

Regular-session close

37.04 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

36.94 Day range 38.37
31.37 52-week range 50.88
YTD
-11.81%
1 year
-9.66%

5D -1.65 (-4.27%)

373839MonTueWedThuFri37.02
Market cap
48.75B
Revenue (ttm)
30.68B
Profit margin
1.85%
EPS (ttm)
0.44
Shares out
878.66M
P/E ratio
84.18
Forward P/E
23.98
YTD return
-11.81%
1-year return
-9.66%
Volume
8.19M
Avg volume
9.51M
Open
37.65
Previous close
37.84
Day's range
36.94 – 38.37
52-week range
31.37 – 50.88
Analysts
Buy
Price target
45.61 (+23.1%)
Earnings date
Feb 24, 2027

Key statistics

50-day average
35.60
200-day average
39.25
Enterprise value
49.86B
Price / sales
1.59
Price / book
2.76
Revenue growth
10.40%
Free cash flow
1.39B
Total cash
3.62B
Total debt
12.65B
Return on equity
4.84%
Short % of float
8.95%

Fundamental scorecard

9 of 25 checks passed on MDLN’s reported financials

ValueGrowthProfitabilityHealthDividend

9of 25 checks passed

  • Value 0 of 5
  • Growth 2 of 5
  • Profitability 3 of 5
  • Financial health 1 of 5
  • Dividend 3 of 5

Statements to Sep 26, 2026.

Financials — quick view

All financials
MDLN Revenue — quarterly 7.86B
MDLN Net income — quarterly 195.00M
MDLN EPS — quarterly 0.23

Earnings

MDLN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 24, 2027Dec 26, 20260.39———
Nov 4, 2026Sep 26, 20260.34320.44+0.10+28.21%
Aug 5, 2026Jun 27, 20260.35240.50+0.15+41.88%
May 6, 2026Mar 31, 20260.29520.33+0.03+11.79%
Feb 25, 2026Dec 31, 20250.23810.2247-0.01-5.63%
Nov 4, 2025Sep 30, 2025—0.31——

Upgrades / downgrades

MDLN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 20, 2026BarclaysmainOverweightOverweight
Nov 5, 2026UBSmainBuyBuy
Nov 5, 2026CitigroupmainBuyBuy
Nov 5, 2026Leerink PartnersmainOutperformOutperform
Nov 5, 2026Evercore ISI GroupmainOutperformOutperform
Nov 5, 2026BTIGreitBuyBuy

About Medline Inc.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
medline.com

News

Your note

Sign in to keep a note on MDLN — it syncs with the Stock Master app.

Insider holders

MDLN insider holders
InsiderRelationLatest transactionDateShares held
BOYLE JAMES M.Chief Executive OfficerConversion of Exercise of derivative securityNov 11, 20260
BX MOZART ML-1 HOLDCO L.P.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityNov 17, 20260
BX MOZART ML-2 HOLDCO L.P.Beneficial Owner of more than 10% of a Class of SecuritySaleMay 27, 20260
CARLYLE GROUP, INC.Beneficial Owner of more than 10% of a Class of SecuritySaleMar 9, 20260
GIC PRIVATE LTDBeneficial Owner of more than 10% of a Class of SecuritySaleOct 7, 20260
HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.PBeneficial Owner of more than 10% of a Class of SecuritySaleMay 27, 20260

Institution ownership

MDLN institution ownership
Holder% heldSharesValueReported
Carlyle Group Inc.21.29%187,083,7136.93BSep 29, 2026
Blackstone Inc11.58%101,791,0083.77BSep 29, 2026
H&f Corporate Investors X, Ltd.8.07%70,874,3262.63BSep 29, 2026
Capital Research Global Investors5.44%47,756,5281.77BSep 29, 2026
FMR, LLC5.06%44,424,9341.65BSep 29, 2026
Invesco Ltd.4.60%40,435,2651.50BSep 29, 2026

Fund ownership

MDLN fund ownership
Holder% heldSharesValueReported
Amcap Fund2.14%18,780,959695.65MSep 29, 2026
Fidelity Contrafund1.66%14,598,531540.73MSep 29, 2026
Growth Fund of America1.58%13,853,297513.13MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.41%12,406,857459.55MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund0.96%8,466,394313.60MJun 29, 2026
MFS SERIES TRUST I-MFS Value Fund0.78%6,853,598253.86MAug 30, 2026